Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Merck Sharp & Dohme B.V.

02 1Merck Sharp & Dohme BV (1)

03 10Merck Sharp & Dohme Bv

04 1Msd Merck Sharp & Dohme Ag

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Pembrolizumab

Brand Name : Keytruda

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 25mg/ml

Packaging :

Approval Date : 18/08/2016

Application Number : 20150808000062

Regulatory Info : Approved

Registration Country : Sweden

blank

02

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Pembrolizumab

Brand Name : Keytruda

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 50mg

Packaging :

Approval Date : 17/07/2015

Application Number : 20140702000015

Regulatory Info : Deregistered

Registration Country : Sweden

blank

03

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Pembrolizumab

Brand Name : KEYTRUDA®

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 25mg/ml

Packaging :

Approval Date : 26-01-2022

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

04

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Pembrolizumab

Brand Name : Keytruda

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 25mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

05

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Pembrolizumab

Brand Name : Keytruda

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 25mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

06

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Pembrolizumab

Brand Name : Keytruda

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 25MG

Packaging :

Approval Date : 23-09-2016

Application Number : 1151024002

Regulatory Info : Authorized

Registration Country : Spain

blank

07

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Pembrolizumab

Brand Name : Keytruda

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 50MG

Packaging :

Approval Date : 10-10-2019

Application Number : 115024001IP

Regulatory Info : Authorized

Registration Country : Spain

blank

08

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Pembrolizumab

Brand Name : Keytruda

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 25MG

Packaging :

Approval Date : 17-10-2019

Application Number : 1151024002IP

Regulatory Info : Authorized

Registration Country : Spain

blank

09

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Pembrolizumab

Brand Name : Keytruda

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 50MG

Packaging :

Approval Date : 31-07-2015

Application Number : 1151024001

Regulatory Info : Cancelled

Registration Country : Spain

blank

10

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Pembrolizumab

Brand Name : Keytruda

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 100mg/4ml

Packaging :

Approval Date : 22/02/2017

Application Number : 66231

Regulatory Info : Allowed

Registration Country : Switzerland

blank